Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
46.91
Price to sales ratio
3.96
Dividends per share
0.28
Dividend yield %
0.29

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
695
MEDP
Medpace Holdings, Inc. - Common Stock
533.47 USD-0.88%-4.90%+11.87%-12.05%15.24 B USD
776
ICLR
ICON plc - Ordinary Shares
166.10 USD-0.97%-3.45%+12.50%+11.57%12.72 B USD
854
CRL
Charles River Laboratories International, Inc. Common Stock
229.88 USD-1.53%-0.80%+23.80%+16.78%11.07 B USD
964
QGEN
Qiagen N.V. Common Shares
41.45 USD-0.17%+4.54%+12.12%-13.38%8.99 B USD

Frequently asked questions about Revvity, Inc. Common Stock

What is the Revvity, Inc. Common Stock stock price today?

The current price of Revvity, Inc. Common Stock (RVTY) is 111.52. Over the past 24 hours, the stock has changed by -0.69%. Follow the RVTY chart for real-time price dynamics.

What is the stock ticker of Revvity, Inc. Common Stock?

Revvity, Inc. Common Stock trades under the ticker RVTY. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Revvity, Inc. Common Stock stock going up?

RVTY has changed by -0.73% over the last week, +7.64% over the last month, and +17.56% over the last year. Review the chart to see whether the current move is part of a broader trend.

Does Revvity, Inc. Common Stock release financial reports?

Yes. You can track Revvity, Inc. Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What was Revvity, Inc. Common Stock net income for the last quarter?

Revvity, Inc. Common Stock reported net income of 98.36 M for the last quarter. The previous quarter showed 46.65 M, which means net income changed by +110.85%.

How many employees does Revvity, Inc. Common Stock have?

As of the latest available data, Revvity, Inc. Common Stock has 11 K employees. Workforce size can provide additional context about the company's scale and operations.

What is Revvity, Inc. Common Stock EBITDA?

Revvity, Inc. Common Stock EBITDA is 229.63 M, and its EBITDA margin is 29.74%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Revvity, Inc. Common Stock stock?

You can buy Revvity, Inc. Common Stock (RVTY) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Revvity, Inc. Common Stock stock?

Investing in Revvity, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RVTY chart and related analysis on metatrader.com as part of your research.

Revvity, Inc. Common Stock

Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines. In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name. The other part, comprising the life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc. From the perspective of Revvity, the goal of creating a separate company was that its businesses might show greater profit margins and more in the way of growth potential. An associated goal was to have more financial flexibility moving forward. On May 16, 2023, the PerkinElmer stock symbol PKI was replaced by the new symbol RVTY.

News